210
Sa10 Retina Hot Topics
Symposium of the DOG 2020 Online
Sa10 Retina Hot Topics
Symposium of the DOG 2020 Online
INTERPLAN AG
Congress, Meeting & Event Management AG
Landsberger Straße 155
DE - 80687 München
Tel.: +49 (0)89 548 234 35
Tel.: +49 (0)89 548 234 0
Fax: +49 (0)89 548 234 43
Fax: +49 (0)89 548 234 44
Chairmen
| Nicole Eter, Münster |
| Horst Helbig, Regensburg |
-
Basisinformation
Datum10.10.2020, 11:30 - 12:15SpracheEnglischGebühren abgebührenfreiVeranstalterDOG - Deutsche Ophthalmologische Gesellschaft e.V.
OrganisatorINTERPLAN AG
Congress, Meeting & Event Management AG
Landsberger Straße 155
DE - 80687 München
Tel.: +49 (0)89 548 234 35
Tel.: +49 (0)89 548 234 0
Fax: +49 (0)89 548 234 43
Fax: +49 (0)89 548 234 44Chairmen
Nicole Eter, Münster Horst Helbig, Regensburg -
Programm
11:30 – 11:39 Sa10-01 - Tell us MacTel
Referent/in: Frank G. Holz, Bonn
Macular telangiectasia type 2 is a bilateral disease of unknown cause with characteristic alterations of the macular capillary network and neurosensory atrophy. Biomicroscopy may show reduced retinal transparency, crystalline deposits, mildly ectatic capillaries, blunted venules, retinal pigment plaques, foveal atrophy, and neovascular complexes. Fluorescein angiography shows telangiectatic capillaries predominantly temporal to the foveola in the early phase and a diffuse hyperfluorescence in the late phase. High-resolution optical coherence tomography (OCT) may reveal disruption of the photoreceptor inner segment-outer segment border, hyporeflective cavities at the level of the inner or outer retina, and atrophy of the retina in later stages. Macular telangiectasia type 2 shows a unique depletion of the macular pigment in the central retina. Recent insights in the pathophysiology of the disease showed that elevated levels of atypical deoxysphingolipids, caused by variant SPTLC1 or SPTLC2 or by low serine levels, were risk factors for macular telangiectasia type 2.11:39 – 11:48 Sa10-02 - ROP in 2020
Referent/in: Andreas Stahl, Greifswald
11:48 – 11:57Sa10-03 - Robotic assisted eye surgery: the iron surgeon
Referent/in: Marc de Smet, Lausanne, Schweiz, Switzerland
11:57 – 12:06 Sa10-04 - Pachychoroid, the new dessous
Referent/in: Sobha Sivaprasad, London, United Kingdom
12:06 – 12:15 Sa10-05 - Aldosteron and the eye: alternative facts
Referent/in: Irmela Mantel, Lausanne, Switzerland
The presentation summarizes results from basic and clinical science with respect to the mineralocorticoid receptor (MR) implication in ocular tissue and chorioretinal diseases. New insight into the molecular pathways of choroidal neovascularization and clinical relevance for age-related macular degeneration will be discussed. Furthermore, the debate of the role of MR in central serous chorioretinopathy will be discussed.
-
Gebühren
Fachärzte/-innenGebühren ab120,00 EURÄrzte/-innen in WeiterbildungGebühren ab120,00 EURStudenten/-innenGebühren abgebührenfreiThe full congress is free for students and PhD students.
-
Buchung / Anmeldung
Please contact the roganizer for further information.
-
Zertifizierung
Keine Zertifizierung beantragt